Ibandronic Acid: all 63 studies that test it

Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.

• The Comparison of Ibandronate and Zoledronic Acid After Denosumab DiscontinuationRecruitingNCT07406685Phase 4
• Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.Not yet recruitingNCT06022237Not applicable
• Efficacy of Oral Ibandronate in OsteoporosisRecruitingNCT03186131Phase 2
• Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple MyelomaTerminatedNCT02739594Phase 3Results posted
• A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal OsteoporosisCompletedNCT02598934Phase 4Results posted
• A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal OsteoporosisCompletedNCT01290094Phase 3Results posted
• Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) PatientsCompletedNCT00824993Phase 3Results posted
• PTH & Ibandronate Combination Study (PICS)CompletedNCT00683163Phase 2/3Results posted
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva TreatmentCompletedNCT00551174Phase 4Results posted
• BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.CompletedNCT00545779Phase 3Results posted
• A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)CompletedNCT00545363Phase 4Results posted
• A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.CompletedNCT00545051Phase 4Results posted
• A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.CompletedNCT00503113Phase 4Results posted
• Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal OsteoporosisCompletedNCT00405392Phase 4Results posted
• The Effect Of Oral Ibandronate In Male OsteoporosisCompletedNCT00397839Phase 3Results posted
• A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.CompletedNCT00377234Phase 4Results posted
• A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)CompletedNCT00303485Phase 4Results posted
• A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With OsteopeniaCompletedNCT00129623Phase 4Results posted
• S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.CompletedNCT00127205Phase 3Results posted
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With BonvivaCompletedNCT00081653Phase 4Results posted
• DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal OsteoporosisCompletedNCT00048074Phase 3Results posted
• MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal OsteoporosisCompletedNCT00048061Phase 3Results posted
• Use of Ibandronate in Diabetic PatientsCompletedNCT05266261Not applicable
• Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without IbandronateCompletedNCT04321837Phase 2
• A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus PlaceboCompletedNCT02948881Phase 4
• A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast CancerCompletedNCT02716792Phase 3
• Study of Oral Bisphosphonate for Osteopenic Women Treated With Adjuvant Aromatase InhibitorsCompletedNCT02616744Phase 2
• A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or OsteopeniaCompletedNCT02604836Phase 4
• PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or OsteopeniaCompletedNCT02598453Phase 4
• A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal OsteoporosisCompletedNCT02598440Phase 4
• A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone DiseaseCompletedNCT02564107Phase 4
• A Study of Ibandronate (Bondronat) in Participants With Malignant Bone DiseaseCompletedNCT02561039Phase 3
• A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast CancerCompletedNCT02553707Phase 4
• Study Comparing Ibandronate Versus Placebo in Hip OsteonecrosisTerminatedNCT02114489Phase 3
• Bioequivalence Study of Ibandronate Sodium Tablets 150 mg Under Fasting ConditionCompletedNCT01627886Phase 1
• Safety and Pharmacokinetic Characteristics of DP-R206 in Healthy Adult VolunteersCompletedNCT01429675Phase 1
• Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term SteroidsCompletedNCT01287533Phase 4
• Steroid Induced Osteoporosis in Patients With Systemic Lupus ErythematosusCompletedNCT00668330Phase 4
• Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsCompletedNCT00666627Phase 2
• Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients CohortWithdrawnNCT00662077Phase 4
• BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal OsteoporosisCompletedNCT00545909Phase 4
• SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.CompletedNCT00545480Phase 4
• A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.CompletedNCT00545207Phase 3
• ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.CompletedNCT00545090Phase 4
• Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-traumatic Osteonecrosis of the Knee: A Randomized Double-blind, Placebo-controlled TrialCompletedNCT00532220Phase 3
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.CompletedNCT00502736Phase 2
• BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.CompletedNCT00493623Phase 3
• Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal MetastasisTerminatedNCT00492843Phase 4
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.WithdrawnNCT00478270Phase 2
• Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary OsteoporosisCompletedNCT00447915Phase 3
• The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral DensityTerminatedNCT00446589Phase 4
• Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.Status unknownNCT00423384Phase 2/3
• Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer PatientsStatus unknownNCT00381368Phase 2
• Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly AlendronateCompletedNCT00327990Phase 4
• Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerStatus unknownNCT00326820Phase 3
• S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the BoneWithdrawnNCT00301886Phase 3
• Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)CompletedNCT00271713Phase 4
• Study in Elderly Patients With Early Breast Cancer (ICE)CompletedNCT00196859Phase 3
• A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus PlaceboCompletedNCT00148915Phase 4
• A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone DiseaseTerminatedNCT00099203Phase 3
• A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe PainTerminatedNCT00099177Phase 3
• Study of Investigational Drug in Osteoporosis (MK-0217-908)CompletedNCT00092053Phase 3
• Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone PainCompletedNCT00082927Phase 3

← Ibandronic Acid overview